Sacheerome
Key Fundamentals
SMEChemicals & PetrochemicalsChemicalsPrice-based figures as of · TTM
- ROCE
- 35.70%
- Debt to Equity
- 0.00
- EPS (TTM)
- —
- Book Value
- ₹66.34
- Market Cap
- —
- P/E (TTM)
- —
- P/B
- 5.98
- ROE
- 27.00%
- Dividend Yield
- 0.00%
- EBITDA
- ₹40.70 Cr
- 52W High
- ₹552.75
- 52W Low
- ₹208.00
- Volume
- 0
Peer Comparison
Commodities › Chemicals › Specialty Chemicals
| ₹1,510.20 | 58.04 | ₹1,54,107 Cr | 13.72 | 1.42% | 23.90% | 31.00% | ₹15,399 Cr | ₹2,677 Cr | |
| ₹4,613.30 | 83.76 | ₹49,073 Cr | 6.04 | 0.07% | 7.82% | 9.64% | ₹5,303 Cr | ₹600 Cr | |
| ₹8,785.00 | 57.03 | ₹44,060 Cr | 10.10 | 0.09% | 19.60% | 21.00% | ₹3,634 Cr | ₹789 Cr | |
| ₹1,578.40 | 27.48 | ₹20,919 Cr | 3.32 | 0.49% | 9.82% | 11.40% | ₹8,575 Cr | ₹784 Cr | |
| ₹1,540.70 | 86.90 | ₹20,030 Cr | 7.88 | 0.00% | 9.66% | 11.90% | ₹1,231 Cr | ₹235 Cr | |
| ₹447.55 | 30.57 | ₹15,838 Cr | 2.59 | 0.23% | 7.13% | 6.86% | ₹9,010 Cr | ₹531 Cr | |
| ₹5,156.50 | 19.67 | ₹14,827 Cr | 2.31 | 0.59% | 11.50% | 14.90% | ₹6,969 Cr | ₹788 Cr | |
| Sacheerome (this company) | ₹396.40 | — | ₹913 Cr | 5.98 | 0.00% | 27.00% | 35.70% | — | — |
| Median 8 companies | ₹1,559.55 | 57.03 | ₹20,474 Cr | 6.01 | 0.16% | 10.66% | 13.40% | ₹6,969 Cr | ₹784 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 81/100
Category scores
- Quality
- 74
- Strong
- Returns, margins, earnings quality 22% weight
- Valuation
- 21
- Poor
- Cheap vs sector & own history 24% weight
- Growth
- 96
- Strong
- Sales & profit trajectory 9% weight
- Financial Health
- 87
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 50
- Average
- Trend strength, vol-adjusted 12% weight
- Ownership
- 25
- Poor
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
3- Company has reduced debt.
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 27.5%
Weaknesses
1- Though the company is reporting repeated profits, it is not paying out dividend
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 10 | 6 | 3 |
| Oscillators | Bearish | 2 | 6 | 1 |
| Moving Averages | Strong Bearish | 8 | 0 | 2 |
Oscillators
Bearish
Overall
Strong Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 39.00
- Neutral
- MACD (12,26,9)
- −23.23
- Bearish
- SMA (50)
- 466.70
- Bearish
- SMA (200)
- 394.06
- Bullish
As of
Growth Rate
From the financial statements below. 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.
Revenue
| 3Y | +29.49% |
|---|---|
| 1Y | +40.74% |
Net profit
| 3Y | +67.11% |
|---|---|
| 1Y | +75.00% |
Operating cash flow
| 3Y | +33.21% |
|---|---|
| 1Y | +18.18% |
Operating margin· change in pp
| 3Y | +10.05 pp |
|---|---|
| 1Y | +3.97 pp |
Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure.
Revenue by year
| Mar 2022 | ₹64.00 Cr |
|---|---|
| Mar 2023 | ₹70.00 Cr |
| Mar 2024 | ₹85.00 Cr |
| Mar 2025 | ₹108 Cr |
| Mar 2026 | ₹152 Cr |
Net profit by year
| Mar 2022 | ₹5.00 Cr |
|---|---|
| Mar 2023 | ₹6.00 Cr |
| Mar 2024 | ₹11.00 Cr |
| Mar 2025 | ₹16.00 Cr |
| Mar 2026 | ₹28.00 Cr |
Half-yearly Results
₹ Cr| Particulars | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 50 | 57 | 77 | 76 |
| Expenses | 41 | 44 | 57 | 58 |
| Operating Profit | 10 | 13 | 19 | 17 |
| OPM % | 19% | 22% | 25% | 23% |
| Other Income | 1 | 0 | 2 | 2 |
| Interest | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 |
| PBT | 10 | 12 | 20 | 18 |
| Tax % | 26% | 25% | 25% | 25% |
| Net Profit | 7 | 9 | 15 | 14 |
| EPS (₹) | 4.32 | 5.47 | 6.68 | 6.03 |
Profit & Loss
₹ Cr| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Sales | 64 | 70 | 85 | 108 | 152 |
| Expenses | 55 | 61 | 70 | 85 | 116 |
| Operating Profit | 9 | 10 | 15 | 22 | 37 |
| OPM % | 13% | 14% | 18% | 21% | 24% |
| Other Income | 0 | 0 | 1 | 1 | 4 |
| Interest | 1 | 1 | 0 | 0 | 0 |
| Depreciation | 2 | 2 | 2 | 2 | 2 |
| PBT | 6 | 8 | 15 | 21 | 38 |
| Tax % | 27% | 28% | 27% | 25% | 25% |
| Net Profit | 5 | 6 | 11 | 16 | 28 |
| EPS (₹) | 2.79 | 3.67 | 6.5 | 9.78 | 12.71 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
₹ Cr| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity Capital | 4 | 4 | 16 | 16 | 22 |
| Reserves | 25 | 31 | 30 | 46 | 126 |
| Borrowings | 8 | 0 | 1 | 3 | 0 |
| Other Liabilities | 11 | 14 | 16 | 19 | 24 |
| Total Liabilities | 49 | 49 | 64 | 84 | 172 |
| Fixed Assets | 9 | 21 | 22 | 23 | 24 |
| CWIP | 0 | 2 | 8 | 28 | 57 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 40 | 27 | 33 | 33 | 90 |
| Total Assets | 49 | 49 | 64 | 84 | 172 |
Cash Flow
₹ Cr| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating | 9 | 11 | 10 | 22 | 26 |
| Investing | −4 | −2 | −10 | −23 | −79 |
| Financing | −6 | −9 | 1 | 2 | 54 |
| Net Cash Flow | −1 | 0 | 1 | 1 | 2 |
| Free Cash Flow | 6 | 9 | 0 | −2 | −14 |
| CFO/EBITDA | 141 | 128 | 91 | 127 | 98 |
Ratios
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debtor Days | 67 | 63 | 68 | 52 | 47 |
| Inventory Days | 113 | 100 | 85 | 61 | 47 |
| Days Payable | 71 | 73 | 73 | 81 | 61 |
| Cash Conversion Cycle | 109 | 89 | 80 | 33 | 33 |
| Working Capital Days | 37 | 63 | 58 | 24 | 31 |
| ROCE % | — | 24% | 36% | 38% | 36% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Sacheerome insights
54 extracted metrics across FY22–FY26.
Documents
- Concall · Sep 2026PPT
- Concall · Jun 2026Transcript PPT
- Concall · May 2026PPT
- Concall · Dec 2025Transcript PPT
- Concall · Aug 2025PPT
- 13 Oct 2026
- 13 Oct 2026
- 13 Oct 2026
- 30 Sep 2026
Frequently Asked Questions about Sacheerome
What does Sacheerome Ltd do?
Where is Sacheerome Ltd (SACHEEROME) listed?
Which sector does Sacheerome Ltd belong to?
What is the 52-week high and low of Sacheerome Ltd?
What is the Return on Equity (ROE) of Sacheerome Ltd?
Company Information
Incorporated in 2009, Sacheerome Ltd is in the business of designing & manufacturing fragrance and flavours
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/SACHEEROME.md for Sacheerome Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.